c19development

Fingerstick COVID-19 Test

Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Fingerstick Test Receives CE Mark for Deployment Across European Union

SPRINGDALE, AR, December 17, 2020 – Effective December 8, 2020, NOWDiagnostics, Inc. has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 ‘antibody fingerstick’ Test for use across 28 countries in the European Union (EU). The test first received CE mark approval for use in moderate/complex laboratory settings on July 28, 2020. The application …

Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Fingerstick Test Receives CE Mark for Deployment Across European Union Read More »

ADEXUSDx® COVID-19 Antibody Test Filed for Point of Care Emergency Use Authorization

SPRINGDALE, Ark., Dec. 10, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that it has filed for expanded Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) of the ADEXUSDx® COVID-19 antibody test for point-of-care (POC)/CLIA waived testing. A prospective clinical trial of the ADEXUSDx® COVID-19 Antibody Test performed across three geographically diverse clinical sites demonstrated a …

ADEXUSDx® COVID-19 Antibody Test Filed for Point of Care Emergency Use Authorization Read More »

ADEXUSDx® COVID-19 Antibody Test Filed for Emergency Use Authorization Confirmed 100% Accurate with BEI Panel

SPRINGDALE, Ark., Dec. 7, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that study results for its ADEXUSDx® COVID-19 antibody test yielded encouraging test performance—providing a strong use case for the innovative diagnostic device, which was filed for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on May 29, 2020. The antibody test  delivered 100 percent sensitivity and …

ADEXUSDx® COVID-19 Antibody Test Filed for Emergency Use Authorization Confirmed 100% Accurate with BEI Panel Read More »

COVID-19 ADEXUSDx

Antibodies might provide lasting COVID-19 resistance

Whether one has long-term immunity to COVID-19 after recovering from the virus is unclear amid a lack of scientific evidence. Still, antibodies might be the key to develop a vaccine and prevent virus reinfection. Two Northwest Arkansas companies have developed tests to detect the presence of virus antibodies. Fayetteville-based Namida Lab Inc. has offered antibody, …

Antibodies might provide lasting COVID-19 resistance Read More »

Get paid for participating in COVID-19 study

FAYETTEVILLE, Ark. (KNWA/KFTA) — Northwest Arkansans can get paid for participating in a COVID-19 study. Now-Diagnostics is asking Washington and Benton County residents to participate in its new COVID-19 diagnostic tests. Now-Diagnostics is sponsoring a clinical study collecting saliva to develop one antigen and one antibody COVID-19 diagnostics test. Interested in learning more? Read full …

Get paid for participating in COVID-19 study Read More »

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity  Independent study confirms revolutionary technology provides accurate results in minutes while requiring no additional reagents or equipment. SPRINGDALE, AR, October 12, 2020 – NOWDiagnostics, Inc. announced today that an independent validation study of the ADEXUSDx® COVID-19 antibody test conducted by the university …

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity Read More »

NWA’s NOWDiagnostics Chosen as Endeavor Entrepreneur at 7th Virtual International Selection Panel

Bentonville, AR — Endeavor concluded the 7th Virtual International Selection Panel (ISP) with the selection of nine new high-impact entrepreneurs representing 1,310 companies from 37 markets around the world, including Northwest Arkansas’ Now Diagnostics entrepreneurs, Kevin Clark and Jeremy Wilson. NOWDiagnostics is a developer and manufacturer of medical devices that deliver an innovative diagnostics testing …

NWA’s NOWDiagnostics Chosen as Endeavor Entrepreneur at 7th Virtual International Selection Panel Read More »

BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home

Monday, August 31, 2020 SPRINGDALE, AR, August 31, 2020 – NOWDiagnostics, Inc. announced today it is working with BARDA, the Biomedical Advanced Research and Development Authority arm of the U.S. Department of Health and Human Services, to develop a serological test for SARS-CoV-2 antibodies that can be used across a variety of health care settings—from clinics …

BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home Read More »

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has received Conformité Européene (CE) mark approval across 28 countries in the EU. With CE approval, our antibody test will be available in a variety of healthcare centers such as clinics and hospital emergency rooms. …

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval Read More »